05/15/2024 6:40 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 11:15 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
04/25/2024 3:40 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
04/25/2024 3:55 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 5:22 PM | Avoro Capital Advisors LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
04/18/2024 7:24 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
|
04/01/2024 11:15 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
04/01/2024 11:15 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
03/20/2024 6:14 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRE 14A | |
03/18/2024 7:31 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
03/01/2024 5:14 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-K/A | |
02/29/2024 4:06 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 3:07 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 8:21 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 PM | Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 3:37 PM | EcoR1 Capital, LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 8:08 AM | Avoro Capital Advisors LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 7:56 AM | Deep Track Capital, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 6:02 AM | RTW INVESTMENTS, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/13/2024 5:46 PM | BCLS II Equity Opportunities, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 8:39 AM | Polar Capital Holdings Plc (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 9:20 AM | FMR LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/08/2024 3:36 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024 8:37 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 424B3 | |
02/05/2024 4:25 PM | McKenna Mark C. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/05/2024 4:29 PM | McKenna Mark C. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:36 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 7:23 PM | King-Jones Heidy (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:27 PM | Burrows Scott L (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:31 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:26 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 4:00 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
12/26/2023 8:56 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/22/2023 5:00 PM | Burrows Scott L (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:00 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/22/2023 3:32 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/13/2023 2:50 PM | PERCEPTIVE ADVISORS LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
12/11/2023 4:41 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
12/08/2023 7:45 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 4:18 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 424B3 | |
11/29/2023 4:08 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
11/28/2023 6:33 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:27 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Stelzer Laurie (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2023 3:32 PM | Albers Jeffrey W. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2023 3:33 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Stelzer Laurie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 3:36 PM | Albers Jeffrey W. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 7:45 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 11:15 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
11/15/2023 4:14 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2023 4:18 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1/A | |
11/14/2023 2:13 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Deutsch Peter E. (Filed by)
| Form SC 13G | |
10/26/2023 8:53 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form DEF 14A | |
10/24/2023 8:00 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 8:36 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 8:40 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRER14A | |
10/06/2023 8:45 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1/A | |
10/05/2023 4:13 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:02 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 4:05 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:15 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) King-Jones Heidy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:06 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Burrows Scott L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:10 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Burrows Scott L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:10 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) King-Jones Heidy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 6:06 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:01 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:02 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:07 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 8:51 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRE 14A | |
07/28/2023 8:01 AM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
07/27/2023 6:01 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:01 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
07/14/2023 3:05 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 3:16 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
07/03/2023 3:20 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Affinity Asset Advisors, LLC (Filed by)
| Form SC 13G | |
06/30/2023 4:24 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
06/30/2023 4:32 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 4:13 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 4:14 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 3:30 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Lawton Alison Frances (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:31 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:32 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Magovcevic-Liebisch Ivana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:33 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Cox Russell J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:34 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Alspaugh Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:20 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) EcoR1 Capital Fund Qualified, L.P. (Filed by)
| Form SC 13G | |
06/23/2023 8:16 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 4:20 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |